| Synonyms: | |
| Status: | Approved (2012) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A08AA11 |
| UNII: | 637E494O0Z |
| InChI Key | XTTZERNUQAFMOF-QMMMGPOBSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C11H14ClN |
| Molecular Weight | 195.69 |
| AlogP | 2.59 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 12.03 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 13.0 |
| Primary Target | |
|---|---|
| 5-HT2C receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
2-210 | - | - | 15-257 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | - | - | 2606 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Obesity | 4 | D009765 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Peripheral Nervous System Diseases | 2 | D010523 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Tobacco Use Disorder | 2 | D014029 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
| Marijuana Abuse | 1 | D002189 | ClinicalTrials |
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 616202-92-7 |
| ChEBI | 65353 |
| ChEMBL | CHEMBL360328 |
| DrugBank | DB04871 |
| DrugCentral | 4374 |
| EPA CompTox | DTXSID3048659 |
| FDA SRS | 637E494O0Z |
| Guide to Pharmacology | 2941 |
| PubChem | 11658860 |
| SureChEMBL | SCHEMBL169382 |
| ZINC | ZINC000006733300 |